Our 3D Ready™ Organoids are a convenient, easy-to-use way for you to start using patient-derived organoids in your work - without the need to culture your own! Explore the potential of organoids for your work without high upfront investment in time or resources, and ensure reliable, reproducible outcomes.
We currently offer multiple, fully characterized organoid lines, all provided in cryopreserved with full protocols, an integrated HUB license and comprehensive scientific support.
Available organoid lines
Breast cancer lines: We currently offer three assay-ready, patient-derived breast cancer organoid lines - ideal for use in small-scale compound screening and disease modeling applications.
Colorectal cancer lines: We currently offer nine colorectal cancer organoid line, representing different mutational profiles and stages of cancer.
Intestinal organoid lines: We currently have two normal duodenal lines available.
Key features
Assay-ready convenience
Our organoids are conveniently available in frozen vials- ready for immediate use whenever you need them.
Integrated HUB Organoid license
An integrated HUB Organoid license for approved proof-of-concept studies reduces the time and expense of getting started.
Reliable, reproducible data
Achieve reliable and reproducible research outcomes with consistent, high-quality organoids.
Get started quickly
Full protocols for use and scientific support mean researchers can start using these cell models without extensive training
Find out how to quickly and easily get started using organoids
Be sure to sign up for our mailing list to stay up to date with the latest 3D biology news, applications, and updates.
Get In Touch
Need ongoing organoid expansion?
3D Ready Organoid Expansion Service
Bioprocess-grown PDOs at scale with validation and quality assurance
Industrial manufacturing of human-derived 3D organoids is now possible with our 3D Ready™ Organoid Expansion Service. This proprietary bioreactor and patent-pending bioprocess technology offers large scale expansion of organoids, by generating high volumes of reproducible organoid models.
Organoids can model complex in vivo processes in vitro. Using human materials, such as Patient-Derived Organoids (PDOs), earlier in research and development provides biotech and pharma with patient-centric models that give more applicable results, potentially enabling a reduction in the use of animals and animal tissues
Making Complex Cell Culture Easy and Efficient with AI
Angeline Lim, PhD, a Senior Application Scientist at Molecular Devices, discusses with News Medical the impact of AI and automation on contemporary drug discovery. She highlights the CellXpress.ai™ Automated Cell Culture System, which leverages machine learning to enhance high-content imaging and cell culture, making workflows more efficient and assays more consistent and dependable.
We empower scientists to advance discovery
We're a trusted life sciences partner to researchers around the world
*Price, time to deliver, and specifications will vary based on mutually agreed technical requirements. Solution requirements may cause adjustment to standard performance.
